{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:30:22Z","timestamp":1789777822645,"version":"4.0.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.lfs.2006.12.001","type":"journal-article","created":{"date-parts":[[2006,12,9]],"date-time":"2006-12-09T12:14:56Z","timestamp":1165666496000},"page":"1073-1079","source":"Crossref","is-referenced-by-count":71,"title":["The effects of biscoclaurine alkaloid cepharanthine on mammalian cells: Implications for cancer, shock, and inflammatory diseases"],"prefix":"10.1016","volume":"80","author":[{"given":"Shinobu","family":"Furusawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lfs.2006.12.001_bib1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/bjc.1995.348","article-title":"Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1","volume":"72","author":"Abe","year":"1995","journal-title":"British Journal of Cancer"},{"issue":"9453","key":"10.1016\/j.lfs.2006.12.001_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(04)17667-8","article-title":"Septic shock","volume":"365","author":"Annane","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.lfs.2006.12.001_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1097-0215(19970717)72:2<295::AID-IJC16>3.0.CO;2-F","article-title":"Overcoming CPT-11 resistance by using a biscoclaurine alkaloid, cepharanthine, to modulate plasma trans-membrane potential","volume":"72","author":"Aogi","year":"1997","journal-title":"International Journal of Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2006.12.001_bib4","first-page":"67","article-title":"Direct antitumor effect of cepharanthin and combined effect with adriamycin against Ehrlich ascites tumor in mice","volume":"15","author":"Asaumi","year":"1995","journal-title":"Anticancer Research"},{"issue":"6","key":"10.1016\/j.lfs.2006.12.001_bib5","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/art.10315","volume":"46","author":"Azuma","year":"2002","journal-title":"Arthritis und Rheum"},{"issue":"6","key":"10.1016\/j.lfs.2006.12.001_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/cbf.1149","article-title":"The role of glutathione in cancer","volume":"22","author":"Balendiran","year":"2004","journal-title":"Cell Biochemistry and Function"},{"issue":"6","key":"10.1016\/j.lfs.2006.12.001_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2174\/1568009054863636","article-title":"P-glycoprotein: implications of metabolism of neoplastic cells and cancer therapy","volume":"5","author":"Breier","year":"2005","journal-title":"Current Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.lfs.2006.12.001_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0031-6997(24)01484-4","article-title":"Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia\/reperfusion injury","volume":"53","author":"Cuzzocrea","year":"2001","journal-title":"Pharmacological Reviews"},{"issue":"20","key":"10.1016\/j.lfs.2006.12.001_bib9","doi-asserted-by":"crossref","first-page":"14553","DOI":"10.1016\/S0021-9258(18)82362-6","article-title":"The mitogen-activated protein kinase signal transduction pathway","volume":"268","author":"Davis","year":"1993","journal-title":"Journal of Biological Chemistry"},{"issue":"11","key":"10.1016\/j.lfs.2006.12.001_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0968-0004(94)90132-5","article-title":"MAPKs: new JNK expands the group","volume":"19","author":"Davis","year":"1994","journal-title":"Trends in Biochemical Sciences"},{"issue":"6","key":"10.1016\/j.lfs.2006.12.001_bib11","first-page":"1165","article-title":"Antitumor effect of cepharanthin in the double grafted tumor system","volume":"17","author":"Ebina","year":"1990","journal-title":"Gan To Kagaku Ryoho"},{"issue":"1","key":"10.1016\/j.lfs.2006.12.001_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0006-2952(91)90012-T","article-title":"Inhibition of 12-O-tetradecanoyl phorbol-13-acetate promoted tumorigenesis by cepharanthine, a biscoclaurine alkaloid, in relation to the inhibitory effect on protein kinase C","volume":"41","author":"Edashige","year":"1991","journal-title":"Biochemical Pharmacology"},{"issue":"9","key":"10.1016\/j.lfs.2006.12.001_bib13","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1349-7006.2002.tb02481.x","article-title":"Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line","volume":"93","author":"Enokida","year":"2002","journal-title":"Japanese Journal of Cancer Research"},{"issue":"10","key":"10.1016\/j.lfs.2006.12.001_bib14","first-page":"4714","article-title":"Macrophages and metastasis: a biological approach to cancer therapy","volume":"45","author":"Fidler","year":"1985","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.lfs.2006.12.001_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pharmthera.2003.08.003","article-title":"Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex","volume":"100","author":"Fujihara","year":"2003","journal-title":"Pharmacology and Therapeutics"},{"issue":"4","key":"10.1016\/j.lfs.2006.12.001_bib16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1254\/jjp.54.464","article-title":"Reversal of resistance to doxorubicin with cepharanthine in murine P388 leukemia cells","volume":"54","author":"Fujimura","year":"1990","journal-title":"Japanese Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.lfs.2006.12.001_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1358\/mf.1998.20.2.485636","article-title":"Cepharanthine inhibits proliferation of cancer cells by inducing apoptosis","volume":"20","author":"Furusawa","year":"1998","journal-title":"Methods and Findings in Experimental and Clinical Pharmacology"},{"issue":"10","key":"10.1016\/j.lfs.2006.12.001_bib18","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1096\/fasebj.13.10.1121","article-title":"Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis","volume":"13","author":"Goodwin","year":"1999","journal-title":"The FASEB Journal"},{"issue":"8","key":"10.1016\/j.lfs.2006.12.001_bib19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.2042-7158.1991.tb03542.x","article-title":"Cepharanthine (biscoclaurine alkaloid) treatment in endotoxic shock of suckling rats","volume":"43","author":"Goto","year":"1991","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"8","key":"10.1016\/j.lfs.2006.12.001_bib20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1368-8375(00)00125-1","article-title":"Characteristics of antitumour activity of cepharanthin against a human adenosquamous cell carcinoma cell line","volume":"37","author":"Harada","year":"2001","journal-title":"Oral Oncology"},{"issue":"2B","key":"10.1016\/j.lfs.2006.12.001_bib21","first-page":"1441","article-title":"Cepharanthine exerts antitumor activity on oral squamous cell carcinoma cell lines by induction of p27Kip1","volume":"23","author":"Harada","year":"2003","journal-title":"Anticancer Research"},{"issue":"3","key":"10.1016\/j.lfs.2006.12.001_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0006-2952(91)90539-H","article-title":"Suppressive effect of biscoclaurine alkaloids on agonist-induced activation of phospholipase A2 in rabbit platelets","volume":"41","author":"Hashizume","year":"1991","journal-title":"Biochemical Pharmacology"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2006.12.001_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(99)00913-9","article-title":"Inhibitory effect of cepharanthine on fibronectin production in growth factor-stimulated rat mesangial cells","volume":"390","author":"Hayama","year":"2000","journal-title":"European Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.lfs.2006.12.001_bib24","first-page":"1543","article-title":"Cepharanthine potentiates the antitumor effect of methylglyoxal bis (cyclopentylamidinohydrazone) on human leukemia cells","volume":"11","author":"Hibasami","year":"1991","journal-title":"Anticancer Research"},{"issue":"10","key":"10.1016\/j.lfs.2006.12.001_bib25","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1158\/0008-5472.CAN-04-3494","article-title":"Nuclear factor-\u03baB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-\u03baB-dependent transcription in cancer cells","volume":"65","author":"Ho","year":"2005","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/j.lfs.2006.12.001_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0304-3835(96)04358-3","article-title":"Synergistic effects of tamoxifen and cepharanthine for circumventing the multidrug resistance","volume":"107","author":"Hotta","year":"1996","journal-title":"Cancer Letters"},{"issue":"3","key":"10.1016\/j.lfs.2006.12.001_bib27","first-page":"309","article-title":"The role the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin","volume":"70","author":"Hsueh","year":"1990","journal-title":"Immunology"},{"issue":"16","key":"10.1016\/j.lfs.2006.12.001_bib28","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1016\/S0021-9258(17)33220-9","article-title":"Relationship between configuration, function, and permeability in calcium-treated mitochondria","volume":"251","author":"Hunter","year":"1976","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/j.lfs.2006.12.001_bib29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1349-7006.2005.00057.x","article-title":"Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells","volume":"96","author":"Ikeda","year":"2005","journal-title":"Cancer Science"},{"issue":"2","key":"10.1016\/j.lfs.2006.12.001_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1254\/jjp.56.195","article-title":"Inhibitory effect of a biscoclaurine alkaloid, cepharanthin, on lung metastasis of Lewis lung carcinoma","volume":"56","author":"Ito","year":"1991","journal-title":"Japanese Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.lfs.2006.12.001_bib31","first-page":"527","article-title":"Potentiation of antitumor activity of vincristine by the biscoclaurine alkaloid cepharanthine","volume":"79","author":"Kato","year":"1987","journal-title":"Journal of the National Cancer Institute"},{"issue":"11","key":"10.1016\/j.lfs.2006.12.001_bib32","first-page":"47","article-title":"Cepharanthin enhances adriamycin sensitivity by synergistically accelerating apoptosis for adriamycin-resistant osteosarcoma cell lines, SaOS2-AR and SaOS2 F-AR","volume":"25","author":"Katsui","year":"2004","journal-title":"International Journal of Oncology"},{"issue":"1","key":"10.1016\/j.lfs.2006.12.001_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/excr.2000.4838","article-title":"Induction of apoptosis by cancer chemotherapy","volume":"256","author":"Kaufmann","year":"2000","journal-title":"Experimental Cell Research"},{"issue":"2","key":"10.1016\/j.lfs.2006.12.001_bib34","first-page":"71","article-title":"Therapeutic experience of venomous snakebites by the Japanese viper (Agkistrodon halys blomhoffii) with low dose of antivenin: report of 43 consecutive cases","volume":"66","author":"Kimoto","year":"1997","journal-title":"Nippon Geka Hokan"},{"issue":"11","key":"10.1016\/j.lfs.2006.12.001_bib35","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1248\/yakushi1947.112.11_837","article-title":"Assay of flow cytometry for the effect of cepharanthine on resistance to doxorubicin","volume":"112","author":"Kisara","year":"1992","journal-title":"Yakugaku Zasshi"},{"issue":"3\u20134","key":"10.1016\/j.lfs.2006.12.001_bib36","first-page":"191","article-title":"Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells","volume":"7","author":"Kisara","year":"1995","journal-title":"Oncology Research"},{"issue":"3","key":"10.1016\/j.lfs.2006.12.001_bib37","first-page":"401","article-title":"Effect of glutathione depletion by buthionine sulfoximine on doxorubicin toxicity in mice","volume":"89","author":"Kisara","year":"1995","journal-title":"Research Communications in Molecular Pathology and Pharmacology"},{"issue":"10\u201311","key":"10.1016\/j.lfs.2006.12.001_bib38","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1515\/BC.2003.152","article-title":"Regulation of the expression of inducible nitric oxide synthase","volume":"384","author":"Kleinert","year":"2003","journal-title":"Biological Chemistry"},{"issue":"1","key":"10.1016\/j.lfs.2006.12.001_bib39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-4165(98)00146-9","article-title":"Potent antiperoxidation activity of the bisbenzylisoquinoline alkaloid cepharanthine: the amine moiety is responsible for its pH-dependent radical scavenge activity","volume":"1426","author":"Kogure","year":"1999","journal-title":"Biochimica et Biophysica Acta"},{"issue":"1","key":"10.1016\/j.lfs.2006.12.001_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-4165(03)00095-3","article-title":"Direct radical scavenging by the bisbenzylisoquinoline alkaloid cepharanthine","volume":"1622","author":"Kogure","year":"2003","journal-title":"Biochimica et Biophysica Acta"},{"issue":"4","key":"10.1016\/j.lfs.2006.12.001_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1254\/fpj.90.205","article-title":"Mode of the anti-allergic action of cepharanthine on an experimental model of allergic rhinitis","volume":"90","author":"Kohno","year":"1987","journal-title":"Nippon Yakurigaku Zasshi"},{"issue":"7","key":"10.1016\/j.lfs.2006.12.001_bib42","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0192-0561(92)90053-N","article-title":"Selective inhibition of T-cell-dependent immune responses by bisbenzylisoquinoline alkaloids in vivo","volume":"14","author":"Kondo","year":"1992","journal-title":"International Journal of Immunopharmacology"},{"issue":"11","key":"10.1016\/j.lfs.2006.12.001_bib43","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/0006-2952(93)90628-A","article-title":"Inhibitory effect of bisbenzylisoquinoline alkaloids on nitric oxide production in activated macrophages","volume":"46","author":"Kondo","year":"1993","journal-title":"Biochemical Pharmacology"},{"issue":"2","key":"10.1016\/j.lfs.2006.12.001_bib44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1014548618440","article-title":"Effects of combination chemotherapy with biscoclaurine-derived alkaloid (Cepharanthine) and nimustine hydrochloride on malignant glioma cell lines","volume":"56","author":"Kono","year":"2002","journal-title":"Journal of Neuro-Oncology"},{"issue":"5","key":"10.1016\/j.lfs.2006.12.001_bib45","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.bcp.2004.11.013","article-title":"Inhibitory effect of 2\u2032-hydroxycinnamaldehyde on nitric oxide production through inhibition of NF-\u03baB activation in RAW 264.7 cells","volume":"69","author":"Lee","year":"2005","journal-title":"Biochemical Pharmacology"},{"issue":"2","key":"10.1016\/j.lfs.2006.12.001_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00024382-200013020-00011","article-title":"Suppression of lethal toxicity of endotoxin by biscoclaurine alkaloid cepharanthin","volume":"13","author":"Maruyama","year":"2000","journal-title":"Shock"},{"issue":"7","key":"10.1016\/j.lfs.2006.12.001_bib47","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0006-2952(90)90271-L","article-title":"Inhibition of active oxygen generation in guinea-pig neutrophils by biscoclaurine alkaloids","volume":"39","author":"Matsuno","year":"1990","journal-title":"Biochemical Pharmacology"},{"issue":"10","key":"10.1016\/j.lfs.2006.12.001_bib48","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1346-8138.2002.tb00199.x","article-title":"Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies","volume":"29","author":"Morita","year":"2002","journal-title":"Journal of Dermatology"},{"issue":"6","key":"10.1016\/j.lfs.2006.12.001_bib49","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1349-7006.2003.tb01482.x","article-title":"Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells","volume":"94","author":"Mukai","year":"2003","journal-title":"Cancer Science"},{"issue":"1","key":"10.1016\/j.lfs.2006.12.001_bib50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1164\/ajrccm.161.1.9808142","article-title":"The prevention of lipopolysaccharide-induced pulmonary vascular injury by pretreatment with cepharanthine in rats","volume":"161","author":"Murakami","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1016\/j.lfs.2006.12.001_bib51","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.shk.0000065768.72937.62","article-title":"Cepharanthin, an alkaloid from Stephania cepharantha, inhibits increased pulmonary vascular permeability in an ovine model of sepsis","volume":"20","author":"Murakami","year":"2003","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.lfs.2006.12.001_bib52","first-page":"131","article-title":"Cepharanthine, an anti-inflammatory drug, suppresses mitochondrial membrane permeability transition","volume":"35","author":"Nagano","year":"2003","journal-title":"Physiological Chemistry and Physics and Medical NMR"},{"issue":"3","key":"10.1016\/j.lfs.2006.12.001_bib53","first-page":"635","article-title":"Beneficial effect of cepharanthine on overcoming drug-resistance of hepatocellular carcinoma","volume":"24","author":"Nakajima","year":"2004","journal-title":"International Journal of Oncology"},{"issue":"6","key":"10.1016\/j.lfs.2006.12.001_bib54","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1055\/s-2006-961536","article-title":"Histamine release inhibition activity of bisbenzylisoquinoline alkaloids","volume":"58","author":"Nakamura","year":"1992","journal-title":"Planta Medica"},{"issue":"4","key":"10.1016\/j.lfs.2006.12.001_bib55","first-page":"471","article-title":"Effect of cepharanthin on radiotherapy induced leucopenia","volume":"35","author":"Ohta","year":"1990","journal-title":"Rinsho Hoshasen"},{"issue":"9","key":"10.1016\/j.lfs.2006.12.001_bib56","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1349-7006.1999.tb00837.x","article-title":"Prevention of lung metastasis by intra-tumoral injection of cepharanthin and staphylococcal enterotoxin B in transplantable rat osteosarcoma","volume":"90","author":"Okada","year":"1999","journal-title":"Japanese Journal of Cancer Research"},{"issue":"14","key":"10.1016\/j.lfs.2006.12.001_bib57","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1089\/aid.1998.14.1239","article-title":"Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells","volume":"14","author":"Okamoto","year":"1998","journal-title":"AIDS Research and Human Retroviruses"},{"issue":"6","key":"10.1016\/j.lfs.2006.12.001_bib58","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0006-2952(01)00692-X","article-title":"Suppression of cytokine production and neural cell death by the anti-inflammatory alkaloid cepharanthine: a potential agent against HIV-1 encephalopathy","volume":"62","author":"Okamoto","year":"2001","journal-title":"Biochemical Pharmacology"},{"issue":"2","key":"10.1016\/j.lfs.2006.12.001_bib59","first-page":"249","article-title":"Antitumor effect of cepharanthin: mechanism of the antimetastatic effect on Lewis lung carcinoma (3LL)","volume":"15","author":"Ono","year":"1988","journal-title":"Gan To Kagaku Ryoho"},{"issue":"1","key":"10.1016\/j.lfs.2006.12.001_bib60","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF00686278","article-title":"Positive interactions between human interferon and cepharanthin against human cancer cells in vitro and in vivo","volume":"35","author":"Ono","year":"1994","journal-title":"Cancer Chemotherapy and Pharmacology"},{"issue":"12","key":"10.1016\/j.lfs.2006.12.001_bib61","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/S1567-5769(01)00127-8","article-title":"Protection of T cells from radiation-induced apoptosis by cepharanthin","volume":"1","author":"Oyaizu","year":"2001","journal-title":"International Immunopharmacology"},{"issue":"5","key":"10.1016\/j.lfs.2006.12.001_bib62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1600-0773.1996.tb00270.x","article-title":"The enhancing effect of tumour necrosis factor-\u03b1 on oxidative stress in endotoxemia","volume":"79","author":"Sakaguchi","year":"1996","journal-title":"Pharmacology and Toxicology"},{"issue":"2","key":"10.1016\/j.lfs.2006.12.001_bib63","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.leukres.2005.06.021","article-title":"Involvement of NF-\u03baB and glutathione in cytotoxic effects of nitric oxide and taxol on human leukemia cells","volume":"30","author":"Santos-Silva","year":"2006","journal-title":"Leukemia Research"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2006.12.001_bib64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-2999(82)90289-8","article-title":"In vitro anti-sickling effect on cepharanthine","volume":"83","author":"Sato","year":"1982","journal-title":"European Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.lfs.2006.12.001_bib65","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/09537100120039334","article-title":"Pharmacological characterization of cepharanthin in chronic idiopathic thrombocytopenic purpura","volume":"12","author":"Sato","year":"2001","journal-title":"Platelets"},{"issue":"9","key":"10.1016\/j.lfs.2006.12.001_bib66","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1211\/0022357044265","article-title":"A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence","volume":"56","author":"Sawicka","year":"2004","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"4","key":"10.1016\/j.lfs.2006.12.001_bib67","first-page":"299","article-title":"Inhibition by biscoclaurine alkaloid of lipid peroxidation in biological membranes","volume":"12","author":"Shiraishi","year":"1980","journal-title":"Physiological Chemistry and Physics"},{"issue":"9","key":"10.1016\/j.lfs.2006.12.001_bib68","first-page":"2413","article-title":"Effect of bisbenzylisoquinoline (biscoclaurine) alkaloids on multidrug resistance in KB human cancer cells","volume":"47","author":"Shiraishi","year":"1987","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/j.lfs.2006.12.001_bib69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0899-5885(02)00046-1","article-title":"The cellular basis of septic shock","volume":"5","author":"Sommers","year":"2003","journal-title":"Critical Care Nursing Clinics of North America"},{"issue":"1","key":"10.1016\/j.lfs.2006.12.001_bib70","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1124\/pr.54.1.101","article-title":"Mitochondria as a pharmacological target","volume":"54","author":"Szewczyk","year":"2002","journal-title":"Pharmacological Reviews"},{"issue":"1A","key":"10.1016\/j.lfs.2006.12.001_bib71","first-page":"165","article-title":"Re-evaluation of antitumor activity of cepharanthin","volume":"22","author":"Terasaka","year":"2002","journal-title":"Anticancer Research"},{"issue":"2\u20133","key":"10.1016\/j.lfs.2006.12.001_bib72","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0005-2728(99)00031-6","article-title":"Nitric oxide in septic shock","volume":"1411","author":"Titheradge","year":"1999","journal-title":"Biochimica et Biophysica Acta"},{"issue":"1","key":"10.1016\/j.lfs.2006.12.001_bib73","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1027335217774","article-title":"The role of reactive oxygen species in mitochondrial permeability transition","volume":"17","author":"Vercesi","year":"1997","journal-title":"Bioscience Reports"},{"issue":"3","key":"10.1016\/j.lfs.2006.12.001_bib74","first-page":"405","article-title":"Cepharanthine enhances in vitro and in vivo thermosensitivity of a mouse fibrosarcoma, FSa-II, based on increased apoptosis","volume":"13","author":"Wang","year":"2004","journal-title":"International Journal of Molecular Medicine"},{"issue":"10","key":"10.1016\/j.lfs.2006.12.001_bib75","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s001090050063","article-title":"Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways","volume":"74","author":"Whitmarsh","year":"1996","journal-title":"Journal of Molecular Medecine"},{"issue":"2","key":"10.1016\/j.lfs.2006.12.001_bib76","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jcb.1155","article-title":"Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines","volume":"82","author":"Wu","year":"2001","journal-title":"Journal of Cellular Biochemistry"},{"issue":"6","key":"10.1016\/j.lfs.2006.12.001_bib77","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0898-6568(01)00278-9","article-title":"Modes of activation of mitogen-activated protein kinases and their roles in cepharanthine-induced apoptosis in human leukemia cells","volume":"14","author":"Wu","year":"2002","journal-title":"Cellular Signalling"},{"issue":"4","key":"10.1016\/j.lfs.2006.12.001_bib78","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3999\/jscpt.20.741","article-title":"Pharmacokinetic disposition of cepharanthine following single and multiple intravenous doses in healthy subjects","volume":"20","author":"Yasuda","year":"1989","journal-title":"Japanese Journal of Clinical Pharmacology and Therapeutics"},{"issue":"5","key":"10.1016\/j.lfs.2006.12.001_bib79","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF01612761","article-title":"Cepharanthine inhibits two-stage tumor promotion by 12-O-tetradecanoylphorbol 13-acetate and mezerein on skin tumor formation in mice initiated with 7, 12-dimethylbenz[\u03b1]anthracene","volume":"117","author":"Yasukawa","year":"1991","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"11","key":"10.1016\/j.lfs.2006.12.001_bib80","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1096\/fasebj.11.11.9285487","article-title":"Cyclooxygenase-2: an essential regulator of NO-mediated apoptosis","volume":"11","author":"von Knethen","year":"1997","journal-title":"The FASEB Journal"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320506009490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320506009490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T08:43:01Z","timestamp":1736671381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320506009490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":80,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0024320506009490"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2006.12.001","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}